These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1461147)

  • 21. Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
    Hazzard WR; Haffner SM; Kushwaha RS; Applebaum-Bowden D; Foster DM
    Metabolism; 1984 Sep; 33(9):779-84. PubMed ID: 6433146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
    Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
    Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
    Frénais R; Nazih H; Ouguerram K; Maugeais C; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria.
    Saku K; Mendoza SG; Laver M; Hynd BA; Gartside PS; Kashyap ML
    Nephron; 1988; 50(2):112-5. PubMed ID: 3146703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1991 Feb; 87(2):536-44. PubMed ID: 1899429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cigarette smoking, adiposity, non-insulin-dependent diabetes, and coronary heart disease in Japanese-American men.
    Fujimoto WY; Leonetti DL; Bergstrom RW; Shuman WP; Wahl PW
    Am J Med; 1990 Dec; 89(6):761-71. PubMed ID: 1979206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1990 Jan; 85(1):144-51. PubMed ID: 2104877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men.
    Kazumi T; Kawaguchi A; Hirano T; Yoshino G
    Metabolism; 2004 May; 53(5):589-93. PubMed ID: 15131762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men.
    Terry RB; Wood PD; Haskell WL; Stefanick ML; Krauss RM
    J Clin Endocrinol Metab; 1989 Jan; 68(1):191-9. PubMed ID: 2909551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.
    Leroux G; Lemieux I; Lamarche B; Cantin B; Dagenais GR; Lupien PJ; Després JP
    Metabolism; 2000 Jan; 49(1):53-61. PubMed ID: 10647064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
    Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
    J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein particles in octogenarians.
    Luc G; Bard JM; Lussier-Cacan S; Bouthillier D; Parra HJ; Fruchart JC; Davignon J
    Metabolism; 1991 Dec; 40(12):1238-43. PubMed ID: 1961114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.
    St-Amand J; Moorjanit S; Lupien PJ; Prud'homme D; Després JP
    Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
    Briand F; Magot T; Krempf M; Nguyen P; Ouguerram K
    Eur J Clin Invest; 2006 Apr; 36(4):224-30. PubMed ID: 16620283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia.
    Rader DJ; Schaefer JR; Lohse P; Ikewaki K; Thomas F; Harris WA; Zech LA; Dujovne CA; Brewer HB
    Metabolism; 1993 Nov; 42(11):1429-34. PubMed ID: 8231838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-I and A-II levels in an Australian population.
    Ma X; Wearne K; Lynch WJ; Masarei JR
    Pathology; 1989 Jan; 21(1):42-5. PubMed ID: 2503807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
    Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
    Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano).
    Chiesa G; Stoltzfus LJ; Michelagnoli S; Bielicki JK; Santi M; Forte TM; Sirtori CR; Franceschini G; Rubin EM
    Atherosclerosis; 1998 Jan; 136(1):139-46. PubMed ID: 9544740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility.
    Weng W; Breslow JL
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14788-94. PubMed ID: 8962133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.